FATE Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Fate Therapeutics Inc

Watchlist Manager

Watchlist

Price: 2.54 USD -1.17% Market Closed

Market Cap: $296.1m

	Fate Therapeutics Inc NASDAQ:FATE	US
T	TMT Steel PCL SET:TMT	TH
	Genocea Biosciences Inc OTC:GNCAQ	US
X	X T L Biopharmaceuticals Ltd TASE:XTLB	IL
	Intellipharmaceutics International Inc TSX:IPCI	CA
J	Jungdawn Co Ltd KOSDAQ:208140	KR
	Platinum Group Metals Ltd TSX:PTM	CA
	AYRO Inc NASDAQ:AYRO	US
	Intelligent Monitoring Group Ltd ASX:IMB	AU
	Gold Springs Resource Corp TSX:GRC	CA
	Gambling.com Group Ltd F:6WH	JE
	Wakou Shokuhin Co Ltd TSE:2813	JP
V	Veeva Systems Inc F:VEE	US
	Jindal Poly Films Ltd NSE:JINDALPOLY	IN
D	Dexcom Inc XMUN:DC4	US

Profitability Summary

Fate Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-2 058%

Negative 3Y Average Operating Margin

-1 748%

Declining Operating Margin

-203% > -2 058%

Negative Net Margin

-1 941%

Negative 3Y Average Net Margin

-1 588%

Declining Net Margin

-177% > -1 941%

Negative Free Cash Flow Margin

-1 628%

Negative 3Y Average Free Cash Flow Margin

-1 215%

Declining Free Cash Flow Margin

-175% > -1 628%

Negative ROE

-61%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-106%

ROIC is Increasing

-113% > -108%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.